Concepedia

Angela Cioffi

AC

Statistics

Publications

34

Citations

4.1K

H-Index

22

Active since

1996

Affiliations

Institut Gustave Roussy(Current)

Institut Bergonié

Centre Léon Bérard

Centre Oscar Lambret

Icahn School of Medicine at Mount Sinai

Angela Cioffi is an author at Institut Gustave Roussy specializing in medicine, oncology, and malignant neoplasms.

ORCID

Publications per year

1996–2018

34

Publications

34

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

, , +13

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

Axel Le Cesne, Isabelle Ray‐Coquard, Binh Bui et al. · The Lancet Oncology · 2010 · 295 citations

, , +8

Advanced chondrosarcomas: role of chemotherapy and survival

Antoîne Italiano, Olivier Mir, Angela Cioffi et al. · Annals of Oncology · 2013 · 249 citations · Full text

, , +10

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes

Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi et al. · The Lancet Oncology · 2011 · 239 citations

, , +5

Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

Patricia Pautier, Anne Floquet, Nicolas Penel et al. · The Oncologist · 2012 · 205 citations · Full text

, , +15

1–5 of 34